Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/07/2010WO2009122404A3 Device for in situ production and topical administration of allicin
10/07/2010WO2009043588A3 Ph regulating antibacterial films for the oral or vaginal cavity
10/07/2010WO2006114014A3 Electrochemical patterning and dissolution of polyelectrolyte multilayers
10/07/2010US20100256671 Tissue sealant for use in noncompressible hemorrhage
10/07/2010US20100256609 Controllable release nasal system
10/07/2010US20100256562 Rapid Infusion System
10/07/2010US20100256210 Methods and compositions for delivering 5-ht3 antagonists across the oral mucosa
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100255118 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
10/07/2010US20100255112 Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
10/07/2010US20100255111 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
10/07/2010US20100255110 Functional agricultural product and method for cultivating the same
10/07/2010US20100255109 Stabilized antioxidant particles, composition comprising the same and method for preparing the same
10/07/2010US20100255108 Combination Treatment of Cancer With Cetuximab and Tetrac
10/07/2010US20100255107 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
10/07/2010US20100255106 Benzothiophenes, formulations containing same, and methods
10/07/2010US20100255105 Extended release pharmaceutical composition comprising metoprolol succinate
10/07/2010US20100255104 Pharmaceutical formulation of taxane
10/07/2010US20100255103 Mesoporous Silica Nanoparticles for Biomedical Applications
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255101 Dextran-based polymer tissue adhesive for medical use
10/07/2010US20100255100 Stabilized protein crystals, formulations comprising them and methods of making them
10/07/2010US20100255099 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
10/07/2010US20100255098 Stereocomplex hydrogels
10/07/2010US20100255096 Compositions And Methods For Transmucosal Delivery Of Domperidone
10/07/2010US20100255095 Pharmaceutical compositions of fenofibrate
10/07/2010US20100255094 Bupropion hydrobromide and therapeutic applications
10/07/2010US20100255093 Sustained release oral dosage forms of an r-baclofen prodrug
10/07/2010US20100255092 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
10/07/2010US20100255091 Oral fast disintegrating tablets
10/07/2010US20100255090 Controlled release matrix pharmaceutical dosage formulation
10/07/2010US20100255089 Pharmaceutical Compositions and Methods of Using Same
10/07/2010US20100255088 Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
10/07/2010US20100255087 oral pharmaceutical composition
10/07/2010US20100255086 Method for oral mucosal absorption of acetyl salycylic acid
10/07/2010US20100255085 Progesterone Solutions for Increased Bioavailability
10/07/2010US20100255084 Medicinal melting capsules for oral mucosal absorption
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255082 Functionally Coated Breakable Tablets
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255080 Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment
10/07/2010US20100255079 Systems and methods for skin rejuvenation
10/07/2010US20100255078 Serpin drugs for treatment of viral infection and method of use thereof
10/07/2010US20100255077 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
10/07/2010US20100255076 Composition and method for dermal regeneration
10/07/2010US20100255075 CR-2 Binding Peptide P28 as Molecular Adjuvant for DNA Vaccines
10/07/2010US20100255074 Transmembrane prostatic acid phosphatase
10/07/2010US20100255073 Composition for transdermal delivery of fentanyl
10/07/2010US20100255072 Dermal delivery device with in situ seal
10/07/2010US20100255071 Patch and patch preparation
10/07/2010US20100255069 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of angelica sinensis, and methods of preparation thereof
10/07/2010US20100255068 Hair-like shaped hydrogels for soft tissue augmentation
10/07/2010US20100255067 Controlled Release Pharmaceutical Compositions of Pregabalin
10/07/2010US20100255066 Orally-administered agent
10/07/2010US20100255065 Method for differenciating mesenchymal stem cell and culturing chondrocytes using alginate coated fibrin/ha composite scaffold
10/07/2010US20100255064 Compressed Chewing Gum Tablet
10/07/2010US20100255063 Compressed Chewing Gum Tablet
10/07/2010US20100255062 Compounds, polymers and methods for treating gastrointestinal dysfunction
10/07/2010US20100255059 Artificial micro-gland
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255054 Pharmaceutical composition for treatment and prevention of restenosis
10/07/2010US20100255050 Polyethylene Based Bioactive Agents
10/07/2010US20100255045 Composition for photodynamic skin treatment
10/07/2010US20100255043 Methods for preparing T-cells for cell therapy
10/07/2010US20100255042 Process for Producing Particles Loaded with Growth Factors as Well as the Particles Thus Obtained
10/07/2010US20100255041 Remedy for the treatment of cardio-vascular diseases or disorders
10/07/2010US20100254914 Nanoworms for in vivo tumor targeting
10/07/2010US20100254909 Thermolabile liposome with a controlled release temperature
10/07/2010US20100254904 Novel therapeutic delivery systems
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010US20100252949 Process for Preparing Pramipexole Dihydrochloride Tablets
10/07/2010DE102009016584A1 Schmelztablette, enthaltend ein Sildenafil-Salz Melting tablet containing a salt of sildenafil
10/07/2010DE102009015002A1 Topical application form, useful for treating e.g. pruritus, burnt skin, dry skin, comprises a carrier material, which is applied with a hydrocolloid matrix and the matrix comprises two hydrocolloids or hydro-gels and one excipient
10/07/2010CA2760564A1 Protein-assisted drug delivery system for the targeted administration of active agents for overcoming blood-brain barrier
10/07/2010CA2757500A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010CA2757463A1 Lyophilization cakes of proteasome inhibitors
10/07/2010CA2757460A1 Hard capsule
10/07/2010CA2757449A1 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
10/07/2010CA2757446A1 Nicotine dissolving film with or without menthol
10/07/2010CA2757418A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
10/07/2010CA2757411A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010CA2757337A1 Modified-release pharmaceutical drug composition
10/07/2010CA2757306A1 Formulation
10/07/2010CA2757190A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010CA2757065A1 Antibacterial composition comprising 4 -isopropyl-3-methylphenol and zinc ions
10/07/2010CA2757032A1 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2756811A1 Liposome composition of eribulin or its pharmacologically permissible salt
10/07/2010CA2699140A1 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/07/2010CA2698996A1 Patch and patch preparation
10/06/2010EP2236160A2 Modified release dimebolin formulations
10/06/2010EP2236159A2 Modified release dimebolin compositions
10/06/2010EP2236147A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
10/06/2010EP2236145A1 Pharmaceutical composition and combined agent
10/06/2010EP2236143A1 Antimicrobial agent for gram-positive bacteria
10/06/2010EP2236135A1 Stable pharmaceutical composition
10/06/2010EP2236133A1 Pharmaceutical composition comprising fentanyl for the treatment of acute or breakthrough pain by sublingual administration
10/06/2010EP2236132A1 Pharmaceutical composition for the treatment of insomnia by sublingual administration
10/06/2010EP2236130A1 Ph-sensitive solid pharmaceutical composition for oral formulation and preparation method thereof
1 ... 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 ... 2991